Answers are grounded in this paper and cite their sources.
Type 1 xanthinuria is characterized by elevated levels of xanthine in blood and urine but near absent amounts of uric acid. In humans, xanthine oxidoreductase (XOR) gene ( XDH ) mutations in type 1 xanthinuria do not affect lifespan whereas Xdh knockout ( Xdh KO) mice die young. High activity allele of hypoxanthine phosphoribosyl transferase (Hprt(high))- Xdh KO- Slc23a4 knockout ( Slc23a4 KO) mice survive to adulthood but exhibit renal damage with a low urinary hypoxanthine/xanthine ratio. Aldehyde oxidase (AOX), a homolog of XOR, is encoded by four genes in mice compared to a single gene in humans. If mouse AOX oxidizes hypoxanthine to xanthine, it could contribute to the observed species differences. Here, DBA/2 background Xdh KO mice with low AOX activity were generated, which exhibit reduced urinary N 1 -methyl-2-pyridone-5-carboxamide (2-Py) excretion and increased urinary hypoxanthine/xanthine ratios. Male C57BL/6 background Hprt(high)- Xdh KO- Slc23a4 KO mice were mated with female DBA/2 mice to obtain 48 DBA/2 background Xdh KO mice. Urine samples were analyzed. In 16 Xdh KO- Slc23a4 KO mice, distribution of the urinary 2-Py/Cr ratio versus the hypoxanthine/xanthine ratio showed an inverse correlation. Future work will involve disrupting Aox2 , Aox3 , and Aox4 , leaving only Aox1 functional in a Hprt(high)- Xdh KO- Slc23a4 KO background to establish a mouse model for human xanthinuria type 1.
No takes yet. Share an insight, caveat, or question.
Terada et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: